Evidence also indicates GLP-1 therapy produces cardiovascular and metabolic improvements beyond weight loss alone, including reductions in blood pressure, inflammatory markers, and fatty liver disease risk
You're below therapeutic threshold
As of April 2026, Rybelsus (oral semaglutide, Novo Nordisk) is the only FDA-approved oral GLP-1 receptor agonist
who want to do a more comprehensive review of these medications and potential ocular side effects, Katz added
Confira os principais benefcios: Aumento da oxidao de gorduras: a l-carnitina facilita o transporte de lipdeos para a mitocndria, promovendo a oxidao de gorduras e contribuindo para a perda de peso e reduo do peso corporal
But its all the more reason to get the widely recommended amount of exercise for general health: 150 minutes (or more) of moderate-intensity exercise and 2 days of resistance training per week